Home/Filings/4/0001209191-22-025171
4//SEC Filing

Kung Winston 4

Accession 0001209191-22-025171

CIK 0001699382other

Filed

Apr 20, 8:00 PM ET

Accepted

Apr 21, 4:25 PM ET

Size

8.6 KB

Accession

0001209191-22-025171

Insider Transaction Report

Form 4
Period: 2022-04-20
Kung Winston
COO, CFO
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2022-04-204,000210,034 total
    Exercise: $3.22Exp: 2028-02-21Common Stock (4,000 underlying)
  • Exercise/Conversion

    Common Stock

    2022-04-20$3.22/sh+4,000$12,88010,600 total
Holdings
  • Stock Option (right to buy)

    (indirect: See footnote)
    Exercise: $3.22Exp: 2028-02-21Common Stock (237,412 underlying)
    237,412
Footnotes (3)
  • [F1]The option is subject to an early exercise provision and is immediately exercisable. The underlying shares vest in accordance with the terms of the option grant.
  • [F2]All of the shares subject to the option are vested and immediately exercisable.
  • [F3]The shares are held of record by the Winston Kung Irrevocable Family Trust for the benefit of the reporting person's immediate family.

Issuer

PMV Pharmaceuticals, Inc.

CIK 0001699382

Entity typeother

Related Parties

1
  • filerCIK 0001666963

Filing Metadata

Form type
4
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 4:25 PM ET
Size
8.6 KB